Colin P N Dinney (Colin P Dinney)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Metastatic Renal Cell Carcinoma

Muscle Invasive Bladder Cancer

Genome Wide Identification

Top Venues

Expert review of anticancer therapy

Bladder cancer (Amsterdam, Netherlands)

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew T Campbell, Amishi Yogesh Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke, Ashish M Kamat, Neema Navai, Colin P N Dinney, Priya Rao, Charles C Guo, Rahul A Sheth, Aradhana M Venkatesan, Rebecca S Slack Tidwell, Shalini Singh Yadav, Aidi Gu, Hong Chen, Marc Macaluso, Fei Duan, Sreyashi Basu, Sonali Jindal, Padmanee Sharma
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle Invasive Bladder Cancer. Cancer research communications (2024)
Alexis R Steinmetz, Sharada Mokkapati, David McConkey, Colin P N Dinney
The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward. Bladder cancer (Amsterdam, Netherlands) 10 (2) (2024)
Alexis R Steinmetz, Sharada Mokkapati, David McConkey, Colin P N Dinney
The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward. Bladder cancer (Amsterdam, Netherlands) 10 (2) (2024)
Côme Tholomier, Alberto Martini, Sharada Mokkapati, Colin P N Dinney
The current status of gene therapy in bladder cancer. Expert review of anticancer therapy (2023)
Sharada Mokkapati, Sima P Porten, Vikram M Narayan, Amy H Lim, Isuru S Jayaratna, Beat Roth, Tiewei Cheng, Neema Navai, Matthew Wszolek, Jonathan Melquist, Ganiraju Manyam, Woonyoung Choi, Bradley Broom, Shanna Pretzsch, Bogdan Czerniak, David J McConkey, Colin P N Dinney
TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Molecular cancer research : MCR 18 (6) (2020)
Devin Plote, Woonyoung Choi, Sharada Mokkapati, Debasish Sundi, James E Ferguson, Jon Duplisea, Nigel R Parker, Seppo Yla-Herttuala, Suo Ctc Bladder Committee, David McConkey, Kimberly S Schluns, Colin P N Dinney
Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation. Oncoimmunology 8 (5) (2019)
Max Kates, Andres Matoso, Woonyoung Choi, Alexander S Baras, Marcus J Daniels, Kara Lombardo, Aaron Brant, Nina Mikkilineni, David J McConkey, Ashish M Kamat, Robert S Svatek, Sima P Porten, Joshua J Meeks, Seth P Lerner, Colin P N Dinney, Peter C Black, James M McKiernan, Chris Anderson, Charles G Drake, Trinity J Bivalacqua
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (4) (2019)
Jonathan J Duplisea, Colin P N Dinney
Should chemotherapy still be used to treat all muscle invasive bladder cancer in the "era of immunotherapy"? Expert review of anticancer therapy 19 (7) (2019)